EUVIMEDEUVIMED entdecken
Crossref

Unlocking clinical quantum oncology through quantum control

Bruno F E Matarèse, Arnie Purushotham

European Journal of Cancer · 2025-08 · 226 · 115632

DOI: 10.1016/j.ejca.2025.115632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025-08. Verfasst von Bruno F E Matarèse und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Cancer and Pharmaceutical Science, King's College London, London WC2R 2LS, UK. Hauptthemen laut MEDLINE: Medical Oncology, Neoplasms, Quantum Theory. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quantum technologies present a transformative frontier for oncology, promising significant advancements in diagnostics, treatment precision, and drug discovery. The clinical realization of this potential is fundamentally reliant on mastering quantum control-the precise manipulation of quantum systems. This perspective details how quantum control is integral across emerging quantum oncology applications, potentially enhancing quantum imaging and quantum sensing by boosting signal sensitivity, improving clarity (e.g., fivefold Signal to Noise Ratio increase), and enabling subcellular visualization. In quantum omics, it could facilitate precise single-cell analysis and drive quantum machine learning for advanced biomarker discovery and validation. For treatment, such precise manipulation could optimise radiation targeting in quantum radiotherapy, could enable real-time tracking for precise quantum surgery, guide targeted delivery in quantum chemotherapy via controlled nanoparticle release, and could enhance the design and precision of quantum immunotherapy and personalised therapies. Overcoming challenges such as coherence and scalability is necessary, but advancements in quantum control are paramount for translating these capabilities into clinical benefits, ultimately improving cancer diagnosis and patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medical OncologyNeoplasmsQuantum TheoryHumans

Stichwörter der Autor:innen

Quantum controlQuantum diagnosticsQuantum machine learningQuantum medicineQuantum treatments

Autor:innen und Institutionen

  • School of Cancer and Pharmaceutical Science, King's College London, London WC2R 2LS, UK.
  • School of Cancer and Pharmaceutical Science, King's College London, London WC2R 2LS, UK. Electronic address: arnie.purushotham@kcl.ac.uk.

Zitieren

APA

Matarèse, B. F. E., & Purushotham, A. (2025). Unlocking clinical quantum oncology through quantum control. European Journal of Cancer, 226, 115632. https://doi.org/10.1016/j.ejca.2025.115632

Vancouver

Matarèse BFE, Purushotham A. Unlocking clinical quantum oncology through quantum control. European Journal of Cancer. 2025;226:115632. doi:10.1016/j.ejca.2025.115632

BibTeX
@article{Matarse2025,
  author = {Matarèse, Bruno F E and Purushotham, Arnie},
  title = {Unlocking clinical quantum oncology through quantum control},
  journal = {European Journal of Cancer},
  year = {2025},
  volume = {226},
  pages = {115632},
  doi = {10.1016/j.ejca.2025.115632}
}
Kostenlos starten →